Elan's nicotine patch
Warner-Lambert will market the smoking cessation product worldwide under an agreement announced Dec. 2. When approved, the patch will be marketed in the U.S. by the company's newly created cardiovascular sales force, which also has responsibility for Lopid. IMS data notes that sales of smoking cessation products in the U.S. will reach nearly $80 mil. in 1988, up from $58 mil. in 1987, with 10% increases expected over the next several years. IMS estimates the worldwide market at about $100 mil.....
You may also be interested in...
The (virtual) doors closing on the J.P. Morgan Healthcare Conference is the sign for the biopharma industry that the new year has truly started, but before we get too far into 2021, Scrip has taken a look at five of the biggest non-COVID-19 story themes of 2020 in no particular order.
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.